Differential Utility Losses in Herpes Zoster Cases Between Vaccinated and Unvaccinated Subjects: A Meta-analysis of Three Clinical Trials.

Nikolaos Giannelos Bernard G Francq Desmond Curran

Published in: Clinical drug investigation (2024)

Recombinant zoster vaccine is effective in alleviating disease severity in breakthrough cases of herpes zoster. The results may be useful in distinguishing QALY losses between vaccinated and unvaccinated cohorts in health economics studies, particularly cost-effectiveness analyses.

Keyphrases

clinical trial
healthcare
public health
mental health
health information
randomized controlled trial
climate change
phase iii